Skip to main content
Industry News
Startup sees endless possibilities for circular RNA

The messenger RNA in vaccines for COVID-19 is linear, and Laronde CEO Diego Miralles says circular or endless RNA -- eRNA for short -- is the next step in the technology's evolution. Circular RNA may be more resistant to exonucleases and immune cells than mRNA, and eRNA therapies might be longer-lasting.

Full Story: